Advertisement
Research Article Free access | 10.1172/JCI112834
Find articles by Moreadith, R. in: JCI | PubMed | Google Scholar
Find articles by Cleeter, M. in: JCI | PubMed | Google Scholar
Find articles by Ragan, C. in: JCI | PubMed | Google Scholar
Find articles by Batshaw, M. in: JCI | PubMed | Google Scholar
Find articles by Lehninger, A. in: JCI | PubMed | Google Scholar
Published February 1, 1987 - More info
Recently, we described a patient with severe lactic acidosis due to congenital complex I (NADH-ubiquinone oxidoreductase) deficiency. We now report further enzymatic and immunological characterizations. Both NADH and ferricyanide titrations of complex I activity (measured as NADH-ferricyanide reductase) were distinctly altered in the mitochondria from the patient's tissues. In addition, antisera against complex I immunoprecipitated NADH-ferricyanide reductase from the control but not the patient's mitochondria. However, immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis of complex I polypeptides demonstrated that the majority of the 25 polypeptides comprising complex I were present in the affected mitochondria. A more detailed analysis using subunit selective antisera against the main polypeptides of the iron-protein fragments of complex I revealed a selective absence of the 75- and 13-kD polypeptides. These findings suggest that the underlying basis for this patient's disease was a congenital deficiency of at least two polypeptides comprising the iron-protein fragment of complex I, which resulted in the inability to correctly assemble a functional enzyme complex.
Images.